PHOTO
Egypt - The Egyptian Exchange’s (EGX) listing committee has decided to list the capital increase shares of Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) (RMDA), the EGX revealed in a statement.
The company’s issued and paid-up capital will be raised to EGP 250 million from EGP 192.15 million.
The capital increase amounts to EGP 57.85 million distributed over 231.40 million bonus shares at a nominal value of EGP 0.25 per share.
The increase will be financed from the company’s retained earnings as per the financial statements of the full-year ended December 2020.
Moreover, stock dividends of 0.3010668748-for-1 bonus shares will be distributed as of September 23rd, 2021, with eligibility for shareholders on a record date of September 22nd, 2021.
Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals.
It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.
Copyright © 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).